ilaprazole: Clinical Trials

8 trials of ilaprazole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 active not recruiting. 8 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 38Completed 7, Active not recruiting 1
Phase 21Completed 1

Follow ilaprazole: new trials by email Literature Review of ilaprazole trials Research Report on ilaprazole

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer
Ilaprazole, Lansoprazole, Ilaprazole Placebo - Peptic Ulcer
Phase 3Active not recruitingIl-Yang Pharm. Co., Ltd.4162024-07-232026-11-06
Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD
Ilaprazole - Non-erosive Reflux Disease
Phase 3CompletedIl-Yang Pharm. Co., Ltd.2772018-10-312021-01-05
Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
Ilaprazole, Omeprazole, Ilaprazole tablet - Peptic Ulcer Hemorrhage
Phase 3CompletedLivzon Pharmaceutical Group Inc.5402014-10-012017-12-06
Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment
Ilaprazole, Pantoprazole - Peptic Ulcer
Phase 3CompletedIl-Yang Pharm. Co., Ltd.3232012-12-012014-06-03
Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients
10 mg ilaprazole, 40mg esomeprazole - Gastroesophageal Reflux Disease
Phase 3CompletedLivzon Pharmaceutical Group Inc.5502011-12-012016-08-09
Efficacy Study of Ilaprazole to Treat Erosive Esophgitis
Ilaprazole, Lansoprazole - Erosive Esophagitis, GERD
Phase 3CompletedIl-Yang Pharm. Co., Ltd.2922010-07-012012-01-12
Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients
5 mg ilaprazole, 10 mg ilaprazole, 10 mg Rabeprazole - Duodenal Ulcer
Phase 2 / Phase 3CompletedLivzon Pharmaceutical Group Inc.4082008-08-012016-07-28
Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3)
10 mg ilaprazole, 20 mg omeprazole - Duodenal Ulcer
Phase 3CompletedLivzon Pharmaceutical Group Inc.4962005-09-012009-08-06

Conditions studied

Duodenal Ulcer (2)  ·  Gastroesophageal Reflux (2)  ·  Peptic Ulcer (2)  ·  Non-Erosive Reflux Disease (1)  ·  Peptic Ulcer Hemorrhage (1)

Sponsors

Il-Yang Pharm. Co., Ltd. (4)  ·  Livzon Pharmaceutical Group Inc. (4)

Countries

South Korea (4)  ·  China (1)

Top investigators

DongHo Lee, MD.PhD (1)  ·  JungSoo Song, M.D. (1)  ·  Kim JinHo (1)  ·  S R Lin, M.D (1)

Results publications

PMID 22070512, PMID 29540336, PMID 38910891